Search -
Gastrointestinal Malignancies: An Issue of Emerging Cancer Therapeutics
Gastrointestinal Malignancies An Issue of Emerging Cancer Therapeutics Author:Wasif Saif, MD, MBBS Emerging Cancer Therapeutics is a quarterly, hard cover, periodical that is designed to provide an up-to-date review of a dedicated emerging cancer therapy topic of interest to clinicians and scientists who are involved in the care of patients receiving cancer treatment. Emerging Cancer Therapeutics will provides a thorough analysi... more »s of recent clinical advances and key clinical research related to cancer therapeutics, including a discussion and assessment of current evidence, current clinical best practice, and likely near future developments. The content is in the form of review articles, but the volume format allows for much more in-depth discussion than the typical journal review article. The goal is to provide for the practicing clinician a source of thorough, ongoing analysis and translational assessment of "hot topics" and areas of rapidly emerging new data in cancer therapeutics with significant implications for clinical care. The coverage of the series encompasses reviews of advances in therapeutics in all the major areas of oncology, both solid and hematologic malignancies, with a focus on advances in medical and biological therapies with emerging clinical impact, and encompassing new technologies with implications for management such as molecular imaging. Features of the Emerging Cancer Therapeutics include: Each volume is focused on a major topic area within cancer therapeutics; Articles include coverage of clinical and translational research developments as well as clinical applications and experience; Articles provide authoritative analyses that are timely yet more in-depth than the typical journal review article; Emphasis is on review of recent evidence and outcomes data Gastrointestinal Malignancies the first issue in Emerging Cancer Therapeuticsprovides a comprehensive and in-depth review of this important group of malignancies. The editors and authors are leaders in their fields who have contributed to develop current standards of care. The chapters update the current screening tools for colon cancers, assessment of predictive markers such as K-RAS and BRAF in the management of colon cancer as well as the state-of-the-art for use of both cytotoxic chemotherapy and the incorporation of the newer biological therapies. Last but not the least, multimodality management is emphasized as only this approach can offer the best chance for a favorable outcome to patients with gastrointestinal (GI) cancers.« less